The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

Once adopted by the FDA and Centers for Disease Control and Prevention, the change could effectively end use of the original ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

The COVID recommendation was part of documents the Food and Drug Administration released Monday that discuss simplifying and ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

This safety concern has not been identified with Moderna's (MRNA.O) bivalent shot and both the CDC and FDA continue to recommend ... EU may pay more for Pfizer COVID shots in return for lower ...